7 Most Promising Robotics Stocks According to Wall Street Analysts

5. Medtronic plc (NYSE:MDT)

Price Target Upside: 15.00%

Year-to-Date Return: 20.32%

Medtronic plc (NYSE:MDT) stands fifth among the most promising stocks. 

TheFly reported on December 18 that Truist Securities maintained its Hold recommendation on MDT but lowered its price objective to $107.00 from $110.00. This revision followed an update to the firm’s valuation models for the medical device sector. Analyst Richard Newitter noted that while MDT’s long-term growth prospects remain intact, the near-term valuation is balanced against macro headwinds.

Separately, on December 22, market sentiment took a turn as TipRanks and other financial outlets reported that Medtronic plc (NYSE:MDT)’s put volume was unusually heavy and directionally bearish. This surge in bearish options activity coincided with the company’s recent operational updates, suggesting that traders were hedging against potential downside despite positive regulatory news.

Recently, on December 19, 2025, the business filed a Form S‑1 registration statement to spin off its Diabetes business as MiniMed, expected to trade on Nasdaq under MMED. The separation allows MDT to focus on higher-growth segments, while MiniMed can pursue its own innovation strategy in diabetes care.

Medtronic plc (NYSE:MDT) is a global medical technology company headquartered in Galway, Ireland, offering innovative medical devices and therapies across cardiac, diabetes, surgical, and neurological care. From a robotics perspective, MDT is a leader in surgical robotics and AI-enabled platforms, including the Hugo robotic-assisted surgery system and advanced navigation ecosystems that enhance precision in minimally invasive procedures.